These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20808660)

  • 1. Understanding the mechanism of toxicity of carbon nanoparticles in humans in the new millennium: A systemic review.
    Sharma M
    Indian J Occup Environ Med; 2010 Jan; 14(1):3-5. PubMed ID: 20808660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles - known and unknown health risks.
    Hoet PH; Brüske-Hohlfeld I; Salata OV
    J Nanobiotechnology; 2004 Dec; 2(1):12. PubMed ID: 15588280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotoxicology: characterizing the scientific literature, 2000-2007.
    Ostrowski AD; Martin T; Conti J; Hurt I; Harthorn BH
    J Nanopart Res; 2009 Feb; 11(2):251-257. PubMed ID: 21170129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
    Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions.
    Stone V; Johnston H; Clift MJ
    IEEE Trans Nanobioscience; 2007 Dec; 6(4):331-40. PubMed ID: 18217626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomaterials and nanoparticles: sources and toxicity.
    Buzea C; Pacheco II; Robbie K
    Biointerphases; 2007 Dec; 2(4):MR17-71. PubMed ID: 20419892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks.
    Lam CW; James JT; McCluskey R; Arepalli S; Hunter RL
    Crit Rev Toxicol; 2006 Mar; 36(3):189-217. PubMed ID: 16686422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop.
    Warheit DB; Borm PJ; Hennes C; Lademann J
    Inhal Toxicol; 2007 Jun; 19(8):631-43. PubMed ID: 17510836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles, nanotechnology and pulmonary nanotoxicology.
    Ferreira AJ; Cemlyn-Jones J; Robalo Cordeiro C
    Rev Port Pneumol; 2013; 19(1):28-37. PubMed ID: 23265236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organization of research team for nano-associated safety assessment in effort to study nanotoxicology of zinc oxide and silica nanoparticles.
    Kim YR; Park SH; Lee JK; Jeong J; Kim JH; Meang EH; Yoon TH; Lim ST; Oh JM; An SS; Kim MK
    Int J Nanomedicine; 2014; 9 Suppl 2(Suppl 2):3-10. PubMed ID: 25565821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the toxicity of selected types of nanochemicals.
    Kumar V; Kumari A; Guleria P; Yadav SK
    Rev Environ Contam Toxicol; 2012; 215():39-121. PubMed ID: 22057930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.
    Tsuji JS; Maynard AD; Howard PC; James JT; Lam CW; Warheit DB; Santamaria AB
    Toxicol Sci; 2006 Jan; 89(1):42-50. PubMed ID: 16177233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabricated nanoparticles: current status and potential phytotoxic threats.
    Yadav T; Mungray AA; Mungray AK
    Rev Environ Contam Toxicol; 2014; 230():83-110. PubMed ID: 24609519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles in Construction Materials and Other Applications, and Implications of Nanoparticle Use.
    Mohajerani A; Burnett L; Smith JV; Kurmus H; Milas J; Arulrajah A; Horpibulsuk S; Abdul Kadir A
    Materials (Basel); 2019 Sep; 12(19):. PubMed ID: 31547011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantum dot cytotoxicity and ways to reduce it.
    Winnik FM; Maysinger D
    Acc Chem Res; 2013 Mar; 46(3):672-80. PubMed ID: 22775328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manufactured nanomaterials: categorization and approaches to hazard assessment.
    Gebel T; Foth H; Damm G; Freyberger A; Kramer PJ; Lilienblum W; Röhl C; Schupp T; Weiss C; Wollin KM; Hengstler JG
    Arch Toxicol; 2014 Dec; 88(12):2191-211. PubMed ID: 25326817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment strategies for nanoscale and fine-sized titanium dioxide particles: Recognizing hazard and exposure issues.
    Warheit DB; Donner EM
    Food Chem Toxicol; 2015 Nov; 85():138-47. PubMed ID: 26362081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle exposures from nano-enabled toner-based printing equipment and human health: state of science and future research needs.
    Pirela SV; Martin J; Bello D; Demokritou P
    Crit Rev Toxicol; 2017 Sep; 47(8):678-704. PubMed ID: 28524743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential toxicity of engineered nanoparticles in mammalian germ cells and developing embryos: treatment strategies and anticipated applications of nanoparticles in gene delivery.
    Das J; Choi YJ; Song H; Kim JH
    Hum Reprod Update; 2016 Sep; 22(5):588-619. PubMed ID: 27385359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.